Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read More
Is Bitcoin About To Soar?
The crypto hype seems to be long in the distant past, eclipsed by buzz over artificial intelligence and machine learning.
But perhaps the nail is not yet in the coffin of the most high profile of all the cryptocurrencies, bitcoin. Recently, some well-known traders have been announcing their entry in the digital coin,
» Read more about: Is Bitcoin About To Soar? »
Read More
Market Commentary: Something Ominous Lurks Beneath
Peak excitement is kicking in now. The market has risen in 15 of the last 17 weeks. Nvidia’s forecasts that beat the street by a couple of billion dollars led to a $250 billion surge in market capitalization. And retail traders are pouring into out-of-the-money call options in the hopes of making life-changing returns on popular stocks.
» Read more about: Market Commentary: Something Ominous Lurks Beneath »
Read More
Get $50,000 Per Year From $3,000 Annual Investment?
Most people think of index funds as boring but that’s because the majority don’t have a good understanding of how these funds actually work. To simplify it, consider the following analogy.
Imagine you’re betting at a horse race but you don’t know which horse will win so you’re permitted to bet on all the horses and whoever wins you win.
» Read more about: Get $50,000 Per Year From $3,000 Annual Investment? »
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
Is This Cathie Wood Stock The Next Big Thing?
Tempus AI (NASDAQ:TEM) has seen its stock run all over the board since its IPO last year. The 52-week range for TEM shares runs from a low of $22.89 to a high of $91.45. This is perhaps unsurprising because Tempus is a young, innovative AI startup.
Since the start of 2025,
» Read more about: Is This Cathie Wood Stock The Next Big Thing? »
Read MoreThe Spotlight
Why Buffett Is All In On This Energy Stock
In recent months, Chevron has garnered attention for winning the confidence of Warren Buffett whose Berkshire Hathaway has taken a large stake. But Chevron’s roots trace all the way back to the 19th century when it was originally part of the Pacific Coast Oil Company.
Since then, Chevron has evolved to become one of the largest and most diversified energy companies in the world,
» Read more about: Why Buffett Is All In On This Energy Stock »
Read MoreThe Daily
Silver shines with a 10 percent rally in last one month, but can it burn brighter?
Any substantial global economic downturn or even partial recession would directly impact the industrial demand for silver, while a prolonged slowdown in Chinese manufacturing or a major policy shift by Beijing could dent the global industrial demand.
International silver prices have clocked a 10 percent rise over the past month,